Canadian Cancer Trials Group Bulletins


News: Advanced radiotherapy improves lung cancer survival

CCTG study BR.28 - international partnership highlighted

The CCTG study BR.28 was led by Dr. Andrea Bezjak from University Health Network - Patients participated at 73 sites in 8 countries!

The article touches on a 10-year University of Manchester and Christie NHS Foundation Trust study which used advanced radiotherapy techniques in patients with limited-stage small cell lung cancer (SCLC) has achieved the best survival rates and lowest toxicity ever reported.

The radiotherapy regimes, given either once-daily or twice daily together with chemotherapy, tripled 5-year survival rates for the hard to treat cancer from 10% in studies conducted in the 1980s with chemotherapy alone to 35% in this study.

See the full article here: